In our 10th Annual Acne and Rosacea Treatment Issue, we touch on many familiar topics, but bring new insights to those and others.
Rosacea Insights
For example, even most dermatologists think of rosacea mainly in terms of its redness. However, this month Dr. Harvey Jay presents a number of patients for whom less-visible symptoms such as painful burning and tingling prove debilitating beyond the embarrassment caused by flushing and redness. Turn to page 48 to read his article.
Acne Research Highlights
And what about acne? Information about of this age-old scourge of adolescence is updated and consolidated in Dr. Lawrence Greene’s CME article “Rationale for Treating Acne with Combination Therapy” (page 56) in which he describes the mechanism(s) of action at work in the wide array of combination treatments now available.
Dr. James Del Rosso, too, weighs in on treatment options with his status report on topical dapsone 5% gel in his “Pharmacotherapy Update” column. Turn to page 66 to read Dr. Del Rosso’s column.
This month, iPLEDGE is once again in the news. Beginning on page 44, Contributing Editor Bonnie Darves provides a look at the 1-year update of the iPLEDGE program, as well as highlights of new disturbing data on the number of pregnancies that occurred since the new program took effect.
Old is New Again
But then there are old issues that are new again. Dr. Noah Scheinfeld presents advantages and disadvantages of a decidedly low-tech approach to acne treatment —comedo extraction (page 52). And Drs. Chantal Barland and Jonette Keri revisit the age-old question previously dismissed as myth: Is there in fact a connection between acne and milk? Turn to page 30 to learn the answer; it might just surprise you.
As for the legal issues related to acne, Dr. Scheinfeld, who is an attorney as well as a dermatologist, discusses litigation concerns stemming from a possible link between inflammatory bowel disease and isotretinoin, which continues to struggle with iPledge adjustment. You can read about this beginning on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
In our 10th Annual Acne and Rosacea Treatment Issue, we touch on many familiar topics, but bring new insights to those and others.
Rosacea Insights
For example, even most dermatologists think of rosacea mainly in terms of its redness. However, this month Dr. Harvey Jay presents a number of patients for whom less-visible symptoms such as painful burning and tingling prove debilitating beyond the embarrassment caused by flushing and redness. Turn to page 48 to read his article.
Acne Research Highlights
And what about acne? Information about of this age-old scourge of adolescence is updated and consolidated in Dr. Lawrence Greene’s CME article “Rationale for Treating Acne with Combination Therapy” (page 56) in which he describes the mechanism(s) of action at work in the wide array of combination treatments now available.
Dr. James Del Rosso, too, weighs in on treatment options with his status report on topical dapsone 5% gel in his “Pharmacotherapy Update” column. Turn to page 66 to read Dr. Del Rosso’s column.
This month, iPLEDGE is once again in the news. Beginning on page 44, Contributing Editor Bonnie Darves provides a look at the 1-year update of the iPLEDGE program, as well as highlights of new disturbing data on the number of pregnancies that occurred since the new program took effect.
Old is New Again
But then there are old issues that are new again. Dr. Noah Scheinfeld presents advantages and disadvantages of a decidedly low-tech approach to acne treatment —comedo extraction (page 52). And Drs. Chantal Barland and Jonette Keri revisit the age-old question previously dismissed as myth: Is there in fact a connection between acne and milk? Turn to page 30 to learn the answer; it might just surprise you.
As for the legal issues related to acne, Dr. Scheinfeld, who is an attorney as well as a dermatologist, discusses litigation concerns stemming from a possible link between inflammatory bowel disease and isotretinoin, which continues to struggle with iPledge adjustment. You can read about this beginning on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
In our 10th Annual Acne and Rosacea Treatment Issue, we touch on many familiar topics, but bring new insights to those and others.
Rosacea Insights
For example, even most dermatologists think of rosacea mainly in terms of its redness. However, this month Dr. Harvey Jay presents a number of patients for whom less-visible symptoms such as painful burning and tingling prove debilitating beyond the embarrassment caused by flushing and redness. Turn to page 48 to read his article.
Acne Research Highlights
And what about acne? Information about of this age-old scourge of adolescence is updated and consolidated in Dr. Lawrence Greene’s CME article “Rationale for Treating Acne with Combination Therapy” (page 56) in which he describes the mechanism(s) of action at work in the wide array of combination treatments now available.
Dr. James Del Rosso, too, weighs in on treatment options with his status report on topical dapsone 5% gel in his “Pharmacotherapy Update” column. Turn to page 66 to read Dr. Del Rosso’s column.
This month, iPLEDGE is once again in the news. Beginning on page 44, Contributing Editor Bonnie Darves provides a look at the 1-year update of the iPLEDGE program, as well as highlights of new disturbing data on the number of pregnancies that occurred since the new program took effect.
Old is New Again
But then there are old issues that are new again. Dr. Noah Scheinfeld presents advantages and disadvantages of a decidedly low-tech approach to acne treatment —comedo extraction (page 52). And Drs. Chantal Barland and Jonette Keri revisit the age-old question previously dismissed as myth: Is there in fact a connection between acne and milk? Turn to page 30 to learn the answer; it might just surprise you.
As for the legal issues related to acne, Dr. Scheinfeld, who is an attorney as well as a dermatologist, discusses litigation concerns stemming from a possible link between inflammatory bowel disease and isotretinoin, which continues to struggle with iPledge adjustment. You can read about this beginning on page 34.
Larisa Hubbs
Executive Editor
lhubbs@hmpcommunications.com
